Natalia Genere, MD; Victor M. Montori, MD, MSc
GIM/FP/GP:
Cardiology:
Endocrinology:
Genere N, Montori VM. Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas. Ann Intern Med. 2018;168:JC8. doi: https://doi.org/10.7326/ACPJC-2018-168-2-008
Download citation file:
© 2019
Published: Ann Intern Med. 2018;168(2):JC8.
DOI: 10.7326/ACPJC-2018-168-2-008
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Healthcare Delivery and Policy.
Results provided by: